4311 - 4320 of 7877 Results
Title
Year
- Intramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologies2020OPENTitle: Intramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologiesJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 295Issue #: 30Start Page: 10138End Page: 10152Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra119.011650Best OA location URL: http://www.jbc.org/article/S0021925817501283/pdfCitation Count: 27
- Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's Disease2020OPENTitle: Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00324Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00324/pdfCitation Count: 7
-
OPENTitle: Unified deep learning approach for prediction of Parkinson's diseaseJournal Name: IET Image ProcessingPublisher: Institution of Engineering and Technology (IET)Vol: 14Issue #: 10Start Page: 1980End Page: 1989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1049/iet-ipr.2019.1526Best OA location URL: https://ietresearch.onlinelibrary.wiley.com/doi/pdfdirect/10.1049/iet-ipr.2019.1526Citation Count: 52
- Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson’s disease2020RESTRICTEDTitle: Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 9Start Page: 2582End Page: 2588Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-09856-7Citation Count: 8
-
OPENTitle: Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 6Start Page: 631End Page: 637Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2019-321759Best OA location URL: https://discovery.ucl.ac.uk/10104877/3/Cole_Manuscript_accepted.pdfCitation Count: 10
-
OPENTitle: Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucoseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 15Issue #: 5Start Page: e0230815End Page: e0230815Publication Date:Open Access(OA) Status: OPENLicense: cc0, cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0230815Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0230815&type=printableCitation Count: 32
-
RESTRICTEDTitle: Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson’s DiseaseJournal Name: DrugsPublisher: Springer Science and Business Media LLCVol: 80Issue #: 8Start Page: 775End Page: 796Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40265-020-01310-2Best OA location URL: https://discovery.ucl.ac.uk/10101152/3/Foltynie_Off%20episode%20review_NV2402%20%282%29Clean.pdfCitation Count: 28
- CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers2020OPENTitle: CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriersJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-020-00192-4Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-020-00192-4Citation Count: 36
- Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease2020OPENTitle: Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00370Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00370/pdfCitation Count: 9
-
OPENTitle: Revised Self-Monitoring ScaleJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000009451Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357291Citation Count: 27